4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Alkermes plc (ALKS) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in Dublin, Ireland with about 2,050 employees. Its market capitalization is roughly $9 billion. In the fiscal year ended 2025-12-31, ALKS reported $1.5B in revenue and $242M in net income.
Alkermes plc, a biopharmaceutical company, engages in the research, development, and commercialization of pharmaceutical products to address unmet medical needs of patients in therapeutic areas in the United States, Ireland, and internationally.
Interactive charts & full statements → Open the ALKS valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $1.5B | $1.6B | $1.7B | $1.1B | — |
| Gross Profit | $1.3B | $1.3B | $1.4B | $894M | — |
| Operating Income (EBIT) | $254M | $421M | $414M | ($6M) | — |
| Net Income | $242M | $367M | $356M | ($158M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $393M | $384M | $394M | $391M | $306M | — |
| Gross Profit | $331M | $338M | $343M | $341M | $257M | — |
| Operating Income (EBIT) | ($48M) | $58M | $89M | $93M | $14M | — |
| Net Income | ($66M) | $49M | $83M | $87M | $22M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $2.5B | $2.1B | $2.1B | $2.0B | — |
| Total Liabilities | $668M | $591M | $934M | $920M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive ALKS viewer.
About TickerBase · Data methodology & sources